Reply to C.F. Hess et al

Affiliations

¹ Patrice P. Carde, Gustave Roussy Cancer Campus, Villejuif, France; Michael Grynberg, Hôpital Jean Verdier, Bondy, France; Catherine Poirot, Hôpital Saint Louis, Paris, France; Bengt Glimelius, Uppsala University Hospital, Uppsala, Sweden; and Nicolas Mounier, L'Archet Hospital, Nice, France.

Comment

Patrice P Carde et al. J Clin Oncol. 2017.

. 2017 Jan 20;35(3):374.

doi: 10.1200/JCO.2016.69.7995. Epub 2016 Oct 28.

¹ Patrice P. Carde, Gustave Roussy Cancer Campus, Villejuif, France; Michael Grynberg, Hôpital Jean Verdier, Bondy, France; Catherine Poirot, Hôpital Saint Louis, Paris, France; Bengt Glimelius, Uppsala University Hospital, Uppsala, Sweden; and Nicolas Mounier, L'Archet Hospital, Nice, France.

No abstract available

Comment on

Balancing the Risk-Benefit Ratio in the Treatment of Patients With Advanced-Stage Hodgkin Lymphoma.
Borchmann P, Engert A. Borchmann P, et al. J Clin Oncol. 2016 Jun 10;34(17):1975-7. doi: 10.1200/JCO.2015.66.3823. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069072 No abstract available.
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
Carde P, Karrasch M, Fortpied C, Brice P, Khaled H, Casasnovas O, Caillot D, Gaillard I, Bologna S, Ferme C, Lugtenburg PJ, Morschhauser F, Aurer I, Coiffier B, Meyer R, Seftel M, Wolf M, Glimelius B, Sureda A, Mounier N. Carde P, et al. J Clin Oncol. 2016 Jun 10;34(17):2028-36. doi: 10.1200/JCO.2015.64.5648. Epub 2016 Apr 25. J Clin Oncol. 2016. PMID: 27114593 Clinical Trial.
How Relevant Is Treatment-Related Infertility for Individual Treatment Selection in Hodgkin Lymphoma?
Hess CF, Schirmer MA. Hess CF, et al. J Clin Oncol. 2017 Jan 20;35(3):372. doi: 10.1200/JCO.2016.69.6575. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28095270 No abstract available.